COMPASSIONATE CANCER CARE MEDICAL GROUP, INC.
NPI: 1548248032
· FOUNTAIN VALLEY, CA 92708
· 174400000X
$5.05M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
23,367 |
$747K |
| 2019 |
20,738 |
$758K |
| 2020 |
22,411 |
$758K |
| 2021 |
22,266 |
$646K |
| 2022 |
23,618 |
$829K |
| 2023 |
19,982 |
$771K |
| 2024 |
10,186 |
$538K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
26,404 |
24,164 |
$1.33M |
| 99214 |
|
27,958 |
26,463 |
$992K |
| 96413 |
|
16,669 |
9,892 |
$452K |
| J9271 |
Inj pembrolizumab |
183 |
148 |
$391K |
| 96367 |
|
11,719 |
6,983 |
$372K |
| 99233 |
Prolong inpt eval add15 m |
9,036 |
2,603 |
$320K |
| 96365 |
|
3,051 |
2,181 |
$161K |
| 96417 |
|
4,318 |
2,886 |
$154K |
| 99205 |
Prolong outpt/office vis |
1,756 |
1,751 |
$134K |
| 99204 |
|
1,882 |
1,880 |
$132K |
| 96375 |
|
5,560 |
3,369 |
$120K |
| 96415 |
|
4,208 |
2,736 |
$104K |
| 99223 |
Prolong inpt eval add15 m |
1,277 |
1,249 |
$77K |
| 99213 |
|
2,553 |
2,473 |
$65K |
| 96372 |
|
4,014 |
1,945 |
$56K |
| 96416 |
|
853 |
548 |
$40K |
| 96368 |
|
1,965 |
1,218 |
$33K |
| 96366 |
|
644 |
470 |
$23K |
| 96521 |
|
1,490 |
866 |
$22K |
| 96361 |
|
818 |
492 |
$15K |
| 96411 |
|
727 |
470 |
$13K |
| J1100 |
Dexamethasone sodium phos |
5,698 |
3,127 |
$9K |
| 99291 |
|
119 |
37 |
$8K |
| 96127 |
|
940 |
932 |
$5K |
| J2405 |
Ondansetron hcl injection |
3,130 |
1,755 |
$4K |
| 99203 |
|
50 |
50 |
$3K |
| J7030 |
Normal saline solution infus |
1,466 |
767 |
$3K |
| 96402 |
|
322 |
309 |
$3K |
| 96401 |
|
323 |
132 |
$2K |
| 85025 |
|
424 |
359 |
$2K |
| J1200 |
Diphenhydramine hcl injectio |
2,713 |
1,569 |
$2K |
| 96360 |
|
47 |
26 |
$2K |
| J3489 |
Zoledronic acid 1mg |
12 |
12 |
$353.27 |
| 96523 |
|
30 |
27 |
$316.29 |
| J2780 |
Ranitidine hydrochloride inj |
97 |
53 |
$310.16 |
| 99000 |
|
50 |
47 |
$259.62 |
| J3490 |
Drugs unclassified injection |
62 |
39 |
$12.10 |